TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT04280640

Intervention type: OTHER
Intervention: Blood Draw
Description: A blood sample will be collected once, prior to treatment.

Intervention type: OTHER
Intervention: Blood Draw
Description: A blood sample will be collected once, prior to treatment.

Intervention type: OTHER
Intervention: Blood Draw
Description: A blood sample will be collected once, prior to treatment.
Study: NCT05328219

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Chewing gums with PEG solution
Description: Patients undergoing colonoscopy under experimental group was advised to take 2L of PEG solution and packets of sugarless sweet mint flavored chewing gums.~The patients are advised to Chew one stick of sugarless gum for at least 10 min after taking each glass of PEG solution and discard the chewing gum before taking next glass.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard of care
Description: Standard of care
Study: NCT05166616

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biopsy
Description: Correlative studies

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Osimertinib
Description: Given PO

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Triptolide Analog
Description: Given PO
Study: NCT04868500

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: AMAZE™ Application
Description: Participants will use the AMAZE™ application to enter daily asthma symptoms and impact to communicate this information to their healthcare provider, as well as access disease educational materials up to six months.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: AMAZE™ Dashboard
Description: Clinical site staff will use the AMAZE™ dashboard for six months to identify usability and barriers, benefits, challenges, ease of implementation, and areas for improvement of the AMAZE™ dashboard in a clinical setting.
Study: NCT05348447

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: cryoanalgesia
Description: intraoperative intercostal nerve freezing for post-operative pain control

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Standard of Care Pain Control
Description: Standard of Care Pain Control Post-operatively
Study: NCT05214482

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AK117
Description: IV infusion,Specified dose on specified days

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Chemotherapy
Description: IV infusion,Specified dose on specified days
Study: NCT05609344

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: SBIRT
Description: Low risk individuals will receive an educational pamphlet about alcohol use and the impact on health. Moderate Risk individuals will receive a brief alcohol intervention. High risk individuals will receive the brief alcohol intervention and be referred to specialty treatment.

Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: SBIRT
Description: Low risk individuals will receive an educational pamphlet about alcohol use and the impact on health. Moderate Risk individuals will receive a brief alcohol intervention. High risk individuals will receive the brief alcohol intervention and be referred to specialty treatment.
Study: NCT04846530

Intervention type: DEVICE
Intervention: RHA® 1, RHA® 2, RHA® 3, and RHA® 4
Description: For each subject, two spaced boluses (0.2 mL each) of the product will be implanted on the same side (left or right side) in the post auricular area of the subject per treatment assignment. The assignment will specify one of the RHA® products to the left ear and another product to the right ear. Each subject will have a total of four boluses.
Study: NCT04927793

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: EDP-938
Description: \[14C\]EDP-938
Study: NCT05786365

Intervention type: DRUG
Intervention: Ketalar 50 MG/ML Injectable Solution
Description: Ketamine will be administered to two different groups as 0.5 mg/kg and 1 mg/kg

Intervention type: DRUG
Intervention: Ketalar 50 MG/ML Injectable Solution
Description: Ketamine will be administered to two different groups as 0.5 mg/kg and 1 mg/kg
Study: NCT05479123

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Propranolol three times a day
Description: Patients with larger (\>2cm) or multiple (\>1) hemangiomas in this arm will get propranolol in the following regimen:~Week 1: 0.5 mg/kg/day divided TID Week 2: 1 mg/kg/day divided TID Week 3: 2 mg/kg/day divided TID. Patients will stay on this dosage until their 3 month follow up visit.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Propranolol twice a day
Description: Patients with larger (\>2cm) or multiple (\>1) hemangiomas in this arm will get propranolol in the following regimen:~Week 1: 0.5 mg/kg/day divided BID Week 2: 1 mg/kg/day divided BID Week 3: 2 mg/kg/day divided BID. Patients will stay on this dosage until their 3 month follow up visit.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Timolol
Description: Patients with a small (\<2cm) isolated infantile hemangioma are prescribed timolol 0.5% ophthalmic drops, a topical beta-blocker(1 drop BID directly onto the hemangioma).
Study: NCT05956808

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Phonak Naida BTE hearing aid
Description: Newest generation of ultra-power Phonak BTE hearing aids

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Phonak Naida BTE hearing aid
Description: Newest generation of ultra-power Phonak BTE hearing aids

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Phonak Naida legacy BTE hearing aid
Description: Previous model/generation of the Naida BTE hearing aid

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Phonak Naida legacy BTE hearing aid
Description: Previous model/generation of the Naida BTE hearing aid
Study: NCT06076928

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Brain Computer Interface integrated HandyRehab platform (BCI-HR)
Description: To test the usability, safety and efficacy of an experimental prototype of a wearable hand robotic glove integrated with brain computer interface system being developed and researched.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: HandyRehab (HR)
Description: A wearable hand robotic glove approved by Health Sciences Authority, class I commercial device

Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Standard Treatment of Care
Description: Standard Conventional Occupational Therapy

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard Treatment of Care
Description: Standard Conventional Occupational Therapy

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Standard Treatment of Care
Description: Standard Conventional Occupational Therapy
Study: NCT06225271

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: the combined intervention of exercise, fruit, and vitamin supplementation
Description: Group intervention~After each intervention, investigators will hold a 15-minute communication and discussion session for the participants. Besides, community health workers will organize at least one health education activity per week during the intervention for no less than 45 minutes.~Individual intervention~Physical activity~The participants will be gathered at the community activity center or day care center. The participants will be allowed to exercise in a way that interests them. The duration of exercise should be longer than 30 minutes.~Fruit supplementation~Consideration of seasonal supply situation and the participants' diabetic status, various types of fruit will be prepared. The fruit will be divided into 50g/100g servings. Participants will be required to eat on site.~Vitamin supplementation~During the intervention, the participants will be required to take 1 tablet of vitamin B complex plus 1 tablet of vitamin C every day.
Study: NCT04834830

Intervention type: DIAGNOSTIC_TEST
Intervention: Pleural effusion will be examined for various cytokines and PD1-lymphocytes.
Description: Examination of pleural effusion
Study: NCT05867537

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Gluten-free diet
Description: Implementation a 78-week dietary intervention to patients with ulcerative colitis, crohn´s disease and UC patients with associated PSC (PSC-IBD).

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Gluten-free diet
Description: Implementation a 78-week dietary intervention to patients with ulcerative colitis, crohn´s disease and UC patients with associated PSC (PSC-IBD).

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Gluten-free diet
Description: Implementation a 78-week dietary intervention to patients with ulcerative colitis, crohn´s disease and UC patients with associated PSC (PSC-IBD).
Study: NCT05996042

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Time-restricted diet
Description: On Tuesdays, Thursdays and Saturdays, only eating is allowed between 7am and 3pm. The rest of the time, only drinking pure water is allowed, which is an eight-hour eating window and a 16-hour fasting period.~On Mondays, Wednesdays and Fridays, under the unified guidance of the physical education teachers of the Health Science Department from 6:00 PM to 7:00 PM, the venue is the gymnasium and sports field of Peking University Health Science Center. The exercise items include aerobics, yoga and comprehensive physical training.

Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Time-restricted diet
Description: On Tuesdays, Thursdays and Saturdays, only eating is allowed between 7am and 3pm. The rest of the time, only drinking pure water is allowed, which is an eight-hour eating window and a 16-hour fasting period.~On Mondays, Wednesdays and Fridays, under the unified guidance of the physical education teachers of the Health Science Department from 6:00 PM to 7:00 PM, the venue is the gymnasium and sports field of Peking University Health Science Center. The exercise items include aerobics, yoga and comprehensive physical training.

Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Time-restricted diet
Description: On Tuesdays, Thursdays and Saturdays, only eating is allowed between 7am and 3pm. The rest of the time, only drinking pure water is allowed, which is an eight-hour eating window and a 16-hour fasting period.~On Mondays, Wednesdays and Fridays, under the unified guidance of the physical education teachers of the Health Science Department from 6:00 PM to 7:00 PM, the venue is the gymnasium and sports field of Peking University Health Science Center. The exercise items include aerobics, yoga and comprehensive physical training.
Study: NCT06190327

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Blended indoor and outdoor multicomponent structured exercise
Description: Participants will receive a 16-week blended indoor and outdoor multicomponent structured exercise program, with 2 sessions per week (90 mins/session). Session 1/week will conduct in indoor setting, while session 2/week will conducted in outdoor setting (park). Each session will comprise 10-min warm-up, 30-min aerobic training, 20-min muscle strength, 20-min postural balance training, and 10-min cool-down.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Indoor-only multicomponent structured exercise
Description: Participants will receive a 16-week indoor-only multicomponent structured exercise program, with 2 sessions per week (90 mins/session). Both two sessions will conducted in indoor setting. Each session will comprise 10-min warm-up, 30-min aerobic training, 20-min muscle strength, 20-min postural balance training, and 10-min cool-down.
Study: NCT05440136

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LY3462817 (SC)
Description: Administered SC.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo (SC)
Description: Administered SC.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LY3462817 (IV)
Description: Administered IV.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo (IV)
Description: Administered IV.
Study: NCT06252818

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: ReHub
Description: ReHub provides support to rehabilitation professionals by offering information for the design, monitoring, and analysis of therapeutic exercise programs for respiratory functional rehabilitation.
Study: NCT05682989

Intervention type: PROCEDURE
Intervention: Urodynamic investigations before and after a mesh surgery protocol.
Description: Urodynamic investigations (The urodynamic study included free uroflowmetry, postvoid residual, filling and voiding cystometry, and a urethral pressure profile. The filling cystometry and urethral pressure profile were performed with 37 degrees C normal saline similar to body temperature at an infusion rate of 80 ml/min.

Intervention type: PROCEDURE
Intervention: Urodynamic investigations before and after a robotic-assisted sacrocolpopexy protocol.
Description: All surgeries were performed using a DaVinci robotic system (Intuitive® Surgical Inc., Sunnyvale, California,US) with standardized technique and materials. Patients were positioned in dorsal lithotomy and steep Trendelenburg position. Trocars were placed bilaterally, and an assistant port was placed laterally. The peritoneum was opened medial to the ureter to develop an avascular space. The mesh was placed on the posterior and anterior vaginal wall and fixed at the level of anterior longitudinal ligaments S1/S2 by sutures. An intraoperative clinical examination was performed to ensure the mesh was in a tension-free position.

Intervention type: PROCEDURE
Intervention: Urodynamic investigations before and after a hysterectomy with trans-vaginal mesh repair
Description: In summary, a vertical incision was made in the anterior vaginal wall to access the vesicovaginal space. The sacrospinous ligament was dissected, and an applicator was inserted and positioned over the SSL. The anchor was fixed to the SSL and the thread was attached to the mesh. The mesh was then adjusted in a tension-free manner, excess mesh was cut, and the incision was closed with suture.
Study: NCT04902664

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Patient education materials
Description: Patients receive a text-message and email with educational materials about medical testing.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Physician peer-comparison email
Description: Physicians receive an email with feedback on how they compare to their peers in aggregate on test ordering during annual physicals.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Physician education materials
Description: Physicians receive reference materials on medical test interpretation and incidental findings.

Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: General visit preparation materials
Description: Patients receive a text-message and email with general visit preparation tips.
Study: NCT05320159

Intervention type: DRUG
Intervention: Secukinumab
Description: Included all the patients treated with secukinumab

Intervention type: DRUG
Intervention: Secukinumab
Description: Included all the patients treated with secukinumab

Intervention type: DRUG
Intervention: Secukinumab
Description: Included all the patients treated with secukinumab

Intervention type: DRUG
Intervention: Secukinumab
Description: Included all the patients treated with secukinumab

Intervention type: DRUG
Intervention: Secukinumab
Description: Included all the patients treated with secukinumab
Study: NCT05348447

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard of Care Pain Control
Description: Standard of Care Pain Control Post-operatively
Study: NCT05616884

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Cementless fixation
Description: Three dimensional printed porous metal, a biomaterial with morphological and mechanical properties that resemble those of native trabecular bone, is now being used for fixation of the tibial component in unicondylar knee arthroplasty. This can reliably achieve osseointegration into the tibia and could lead to a lower risk of aseptic loosening which is the leading cause of revision in partial knee replacements.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Cementless fixation
Description: Three dimensional printed porous metal, a biomaterial with morphological and mechanical properties that resemble those of native trabecular bone, is now being used for fixation of the tibial component in unicondylar knee arthroplasty. This can reliably achieve osseointegration into the tibia and could lead to a lower risk of aseptic loosening which is the leading cause of revision in partial knee replacements.
Study: NCT05021549

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: nasal prong
Description: apneic preoxygenation group (30 patients), will receive 10 L/ min of O2 via nasal prong during preintubation apnia
Study: NCT05670392

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: laser and High intensity Tesla magnetic stimulation
Description: Three (3) non-ablative Er:YAG laser treatments will be applied at monthly intervals followed by Eight (8) HITS therapies) Patients will receive two (2) HITS treatments per week for four (4) weeks(.

Intervention type: DEVICE
Group type: OTHER
Intervention: laser (without HITS treatment)
Description: Three (3) non-ablative Er:YAG laser treatments will be applied at monthly intervals as described above.
Study: NCT05796765

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Micronized DHACM 40 mg
Description: Injection of 40 mg allogeneic micronized dehydrated human amnion chorion membrane (DHACM) suspended in 2.5 mL, 0.9% Sodium Chloride, USP

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Micronized DHACM 100 mg
Description: Injection of 100 mg allogeneic micronized dehydrated human amnion chorion membrane (DHACM) suspended in 2.5 mL, 0.9% Sodium Chloride, USP

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Saline
Description: Injection of 2.5 ml, 0.9% Sodium Chloride, USP
Study: NCT06486272

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Financial Navigator
Description: Intervention: Access to a Financial Navigator We anticipate the Financial Navigator will meet at least 2 times and up to 2 additional visits, at a time convenient for the family. Examples of financial services that will likely be offered by the Financial Navigator are tax filing, applying for benefits and financial counseling. The program will be flexible and family centered. Families can choose if they would like to meet the Financial Navigator in person at the NNFU appointment, during another medical appointment, or at another time during a virtual visit. The Financial Navigator will be integrated into the existing SickKids Resource Navigation Service. At the 18-month NNFU visit the study will be completed.
Study: NCT06476158

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Kaiku Health
Description: Digital follow-up with Kaiku Health as medical device
Study: NCT04761484

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Vascular access on admission
Description: PIVC insertion
Study: NCT03877653

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Wireless neuromodulation
Description: A needle and catheter are carefully inserted near the enervated nerve. The stimulator is then placed through the catheter close to the nerve. The proximal end of the stimulator is then sutured underneath the skin to prevent migration.

Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Wireless neuromodulation
Description: A needle and catheter are carefully inserted near the enervated nerve. The stimulator is then placed through the catheter close to the nerve. The proximal end of the stimulator is then sutured underneath the skin to prevent migration.
Study: NCT06013280

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Progresive Muscle Relaxation and Breathing Exercise
Description: Intervention protocol contains 40 minuntes sessions, which involved tensing and relaxing the body along with deep breathing.~Protocol consisted with; Warm-up (5 minutes breathing exercise) Progressive Muscle Relaxation Exercises (The participants performed PMR for each body part in a particular order, beginning with the face muscles and head, followed by neck, shoulders, chest, abdomen, legs, and feet. This muscle tensing and relaxing procedures were performed in accompaniment with deep breathing.) Cool-down (5 minutes breathing exercise)
Study: NCT05342337

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Telerehabilitation Group
Description: The Telerehabilitation program includes a Biopsychosocial Exercise Therapy (BETY) approach.~BETY approach includes patient education on pain, functional body stabilization exercises (mind-body information management), dance therapy authentic movement (emotion-state information management), and sexual information management.~Telerehabilitation group participate in the sessions that last for one and a half hours, 3 days a week for 12 weeks, video conference over the Zoom program. The investigator, who provides supervision during the sessions, also participates in the exercises simultaneously.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Control group
Description: The control group participants include those who do not want to receive exercise treatment with telerehabilitation and take their routine medications during the 12 weeks period.
Study: NCT06218706

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Low Intensity Focussed Ultrasound
Description: The major objective of this study is to further test safety, tolerability, and feasibility of LIFU in this population as well as investigate the impact of LIFU on opioid and other substance use. The primary endpoint is 90 days (Post-LIFU Week 12) following Active/Sham LIFU. After the primary endpoint is reached, the blind will be broken and the group who received Sham LIFU will cross-over and receive Active LIFU

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Low Intensity Focussed Ultrasound
Description: The major objective of this study is to further test safety, tolerability, and feasibility of LIFU in this population as well as investigate the impact of LIFU on opioid and other substance use. The primary endpoint is 90 days (Post-LIFU Week 12) following Active/Sham LIFU. After the primary endpoint is reached, the blind will be broken and the group who received Sham LIFU will cross-over and receive Active LIFU
Study: NCT05260333

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Butterfly iQ transperineal ultrasound exam
Description: Transperineal ultrasound
Study: NCT06246071

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TYK-00540
Description: TYK-00540 PO, BID
Study: NCT05251532

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Kinesio Taping
Description: In addition to Kinesio Tex tape distortion taping, conventional rehabilitation is applied.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Conventional Rehabilitation
Description: Conventional rehabilitation practices are carried out
Study: NCT06343194

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Bruxoff ®
Description: Bruxoff ® is a holter that measures the masseter muscle contraction and heart rate.